1360441-69-5

Upstream product

• 1360441-57-1 5-(3,4-dichlorophenyl)-2,5-ethano-2,3,4,5-tetrahydro-1H-benzo[c]azepin-8-ol 
• 1360441-54-8 5-(3,4-dichlorophenyl)-8-methoxy-2,5-ethano-2,3,4,5-tetrahydro-1H-benzo[c]azepine 
• 1360441-51-5 4-(3,4-dichlorophenyl)-1-(3-methoxybenzyl)piperidin-4-ol 
• 904750-10-3 8-(3-methoxybenzyl)-1,4-dioxa-8-azaspiro[4.5]decane 
• 1360439-95-7 6-bromo-3,3a-dihydrobenzo[d]oxazol-2(7aH)-one 
• 1360441-61-7 5-(3,4-dichlorophenyl)-2,5-ethano-2,3,4,5-tetrahydro-1H-benzo[c]azepin-8-yl trifluoromethanesulfonate 
• 163341-33-1 1-(3-methoxybenzyl)piperidin-4-one 
• 177-11-7 4,4-ethylenedioxy-piperidine 
• 591-31-1 3-methoxy-benzaldehyde 

Downstream Products

• 1360441-70-8 6-(5-(3,4-dichlorophenyl)-2,5-ethano-2,3,4,5-tetrahydro-1H-benzo[c]azepin-8-yl)-3,3a-dihydrobenzo[d]oxazol-2(7aH)-one, L-tartrate salt 

Relevant academic research and scientific papers

2,5-Methano- and 2,5-Ethano-Tetrahydrobenzazepine Derivatives And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, and Serotonin

The compounds of the present invention are represented by the following 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives having formula (I): where the carbon atom designated * is in the R or S configuration when n is 1 and the substituents X and R1-R7 are as defined herein.